{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-219617","form_type":"8-K","ticker":"BCAX","cik":"0002023658","company_name":"Bicara Therapeutics Inc.","filed_at":"2024-09-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.379013+00:00","generated_at":"2026-05-31T04:46:55.103620+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Bicara Therapeutics files amended charter and bylaws post-IPO, increases authorized shares to 500M","bullets":["Authorized 500 million shares of common stock and 10 million shares of undesignated preferred stock.","Eliminated stockholder ability to act by written consent and to call special meetings.","Established advance notice procedures for stockholder proposals and director nominations.","Amendments effective immediately prior to completion of IPO, as previously disclosed in S-1."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-219617","json":"https://secwatch.observer/filing/0001193125-24-219617.json","markdown":"https://secwatch.observer/filing/0001193125-24-219617.md","text":"https://secwatch.observer/filing/0001193125-24-219617.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2023658/000119312524219617/0001193125-24-219617-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2023658/000119312524219617/d844648d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T04:46:55.103620+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}